Daniel Kuba

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

Oncology, Hepatology, Medicine +10

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 91 citations · Full text

Copper Oxide Nanoparticles Stimulate the Immune Response and Decrease Antioxidant Defense in Mice After Six-Week Inhalation

Jana Tulinská, Miroslava Lehotská Mikušová, Aurélia Líšková et al. · Frontiers in Immunology · 2022 · 62 citations · Full text

Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients

Katarı x na Poláková, M Kŕcová, Daniel Kuba et al. · Leukemia Research · 2003 · 40 citations

Hla, Hematological Malignancy, Malignant Hematopoetic Cells +11

Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients

Katarína Šoltýs, Martina Stuchlíková, Tibor Hlavatý et al. · Scientific Reports · 2020 · 38 citations · Full text

Nutrition, Chronic Inflammatory Diseases, Dysbiosis +16